John Ken Delano LPC

Recommended Articles

• What Is Indigestion? Get the Facts

  Indigestion, also known as heartburn, is a common term used to describe the discomfort or pain felt in the upper abdomen just below the ribs. It is not a disease. It is merely a symptom and it can be just another symptom of many digestive problems. The main complaint of those who experience...

• Reasons Why You Need a Radiation Therapy

  Radiation therapy is one of the several treatment methods available for cancer. It is used to treat many different types of cancer. At least half of the patients with cancer receive radiation therapy during their cancer treatment. Radiation therapy can be used as the main treatment for your cancer...

• Rosehip Oil: Characteristics, Constituents, Benefits and Uses

  Introduction to Rosehip OilWhat is it that is keeping the skin of all the famous personalities so smooth and blemish free? What is it that they all have in common? It has been said that they all use rosehip oil to maintain a smooth and acne or blemish free skin. Due to its amazing healing...

• Diarrhea: The Top 10 Questions

  Is diarrhea a sign of early pregnancy?Diarrhea is a very common sign of early pregnancy. Every woman is different and so are her experiences of pregnancy. Not every woman experiences the same symptoms. Hence, diarrhea is also not a symptom that every pregnant woman experiences, although it’s quite...

• New Lung Cell Type Discovered May Be a Key to Efforts to Cure CF

  After years and years of studying the CFTR (cystic fibrosis transmembrane conductance regulator) gene and progress in the treatment of cystic fibrosis, researchers still have not been able to find a cure for the disease. But now, based on the findings of two independent studies, they are moving one...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...